top of page
BPIQ Blog
Aug 9, 20221 min read
Biopharma Daily Pulse - 08/09/22
$XBI $90.75 | -3.34% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to...
Aug 9, 20221 min read
Free Biopharma Daily Pulse - 08/09/22
$XBI $90.75 | -3.34% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to...
Aug 9, 20221 min read
Biopharma Mid Morning Pulse - 08/09/22
(Posted 10:07am CST) $XBI $91.00 | -3.08% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Aug 9, 20221 min read
Free Biopharma Mid Morning Pulse - 08/09/22
(Posted 10:07am CST) $XBI $91.00 | -3.08% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Jul 1, 20222 min read
Biopharma Pulse - 6/27-7/1 Week in Review
As we reach the end of June, we review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and...
Jun 30, 20222 min read
Biopharma Daily Stock Updates - 06/30/22
$XBI $74.27 | -0.71% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #HGEN -4% NIH/NIAID Locks...
Jun 30, 20222 min read
Free Biopharma Daily Stock Updates - 06/30/22
$XBI $74.27 | -0.71% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #HGEN -4% NIH/NIAID Locks...
Jun 14, 20221 min read
Biopharma Daily Stock Updates - 06/14/22
$XBI $63.42 | +0.16% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates # Pipeline Updates #OTLK +16%...
Jun 14, 20221 min read
Free Biopharma Daily Stock Updates - 06/14/22
$XBI $63.42 | +0.16% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates # Pipeline Updates #OTLK +16%...
Jun 22, 20214 min read
COVID-19 Therapeutic Stocks to Watch (June 2021)
Summary Over 40 Smid-Cap companies currently have active trials involving COVID therapeutics (this includes small molecules and...
Apr 29, 20195 min read
FDA Decision on Heron's Non-Opioid Pain Med Imminent
We think Heron (HRTX) has a very good chance of approval by the FDA by the April 30, 2019 due date for its non-opioid pain med HTX-011....
Mar 12, 20191 min read
HRTX Opioid-Free Pain Med Candidate Continues to Impress
Yesterday, Heron (HRTX) reported additional data for its opioid-free pain med candidate HTX-011 in a post-surgery setting. In the latest...
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page